InvestorsHub Logo
Followers 22
Posts 996
Boards Moderated 0
Alias Born 08/01/2016

Re: None

Monday, 04/03/2017 6:46:44 AM

Monday, April 03, 2017 6:46:44 AM

Post# of 462568
Looks like same AMAZING news : ALZ patients stable after a full year with a subset returning to normal baseline! This alone should be trading at $50. Then add in moving to phase 2 trials ins Rhetts and Parkinson $60, then add in Phase 2/3 trials beginning this year $70, BIIB testing, add in a poison pill and plenty of cash, $75 fair value now.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News